作者: Tao Li , Bang-Wei Cao , Yue Dai , Hong Cui , Hong-Li Yang
DOI: 10.1111/J.1440-1746.2008.05324.X
关键词: Internal medicine 、 Genetic predisposition 、 Transforming growth factor 、 Stomach cancer 、 Genotype 、 Transforming growth factor beta 、 Carcinogenesis 、 Cancer 、 Oncology 、 Haplotype 、 Medicine 、 Endocrinology
摘要: Background and Aim: As an important cytokine that modulate the cell cycle, involvement of transforming growth factor beta-1 (TGF-β1) in carcinogenesis has been extensively studied for many years. Literatures have demonstrated TGF-β1 gene polymorphisms may alter risk various cancers, such as lung, prostate breast. To investigate whether can modify gastric cancer, we conduct this hospital-based, case-control study. Methods: One hundred sixty-seven cases 193 gender, age-matched healthy controls were enrolled study. C-509T T + 869C identified by PCR-RFLP ARMS-PCR protocols, respectively. Results: Significantly different distributions both genes between case control. Variant genotypes −509CT, −509TT, +869TC +869CC associated with increased cancer (P = 0.001, OR = 2.54; P = 0.016, OR = 2.09; P < 0.001, OR = 3.46; OR = 4.04, respectively). With haplotype analysis, wild type CT (−509C +869T) led to a lower frequency than control (P < 0.001), while TC was more frequent (P < 0.001). Multiple logistic regression analysis revealed individuals had likelihood developing (OR = 3.19, 95%CI = 1.72–5.90). Conclusions: Our findings imply −509C > T +869T > C be critical genetic susceptibility Chinese population.